Loading...
You are here:  Home  >  2017  >  February  >  20
Latest

Chinese affordable lung cancer drug hits market

By   /  February 20, 2017  /  All News  /  No Comments

Updated: Feb 20,2017 10:14 AM     Xinhua JINAN — A generic targeted drug to treat cancer manufactured by a Chinese pharmaceutical company hit market over the weekend. The new gefitinib cancer-treating drug, whose Chinese commercial name is Yiruike, was produced by Qilu Pharmaceutical (Qilu). Its release ends an almost decade-long monopoly by Iressa, developed by British […]

Read More →
Skip to toolbar